Ovensa Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Ovensa Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11092
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥33,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥67,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥101,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Ovensa Inc (Ovensa) is a preclinical stage company that develops nanotherapeutics. The company uses its proprietary Triozan Nanomedicine delivery platform that has mucosal and brain-barrier crossing properties used in treatment of oncology and neurodegenerative diseases. Its Triozan helps in the delivery of various drugs across multiple barriers such as blood-brain barrier, buccal, bronchial, cornea and conjunctiva, dermal, female reproductive tract, gastrointestinal tract, nasal, and others. Ovensa’s platform find applications in the mucosal delivery of peptides, vaccines, DNA and RNA, gene-based therapies, and other biologics and conventional small molecules. The company also conducts programs for the treatment of metastatic breast cancer, glioblastoma, autism, Alzheimer’s disease, and other diseases. It partners with pharmaceutical and biotech companies. Ovensa is headquartered in Aurora, Ontario, Canada.

Ovensa Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Ovensa Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Ovensa Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Ovensa Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Ovensa Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Ovensa Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Ovensa Inc, Pharmaceuticals & Healthcare, Deal Details 10
Licensing Agreements 10
Ovensa Enters into Licensing Agreement with Aligo Innovation 10
Ovensa Enters into Licensing Agreement with SOCPRA 11
Gestion Socpra Enters into Licensing Agreement with Ovensa 12
Ovensa Inc – Key Competitors 13
Ovensa Inc – Key Employees 14
Ovensa Inc – Locations And Subsidiaries 15
Head Office 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
Ovensa Inc, Pharmaceuticals & Healthcare, Key Facts 2
Ovensa Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Ovensa Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Ovensa Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Ovensa Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Ovensa Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Ovensa Enters into Licensing Agreement with Aligo Innovation 10
Ovensa Enters into Licensing Agreement with SOCPRA 11
Gestion Socpra Enters into Licensing Agreement with Ovensa 12
Ovensa Inc, Key Competitors 13
Ovensa Inc, Key Employees 14

List of Figures
Ovensa Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Ovensa Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Ovensa Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Ovensa Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Ovensa Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Ovensa Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Ovensa Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Ovensa Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Ovensa Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Edwards Lifesciences Corp (EW)-製薬・医療分野:企業M&A・提携分析
    Summary Edwards Lifesciences Corp (Edwards) is a global medical technology company, which focuses on the development, manufacture and marketing of products and technologies used for the treatment of structural heart disease and critical conditions. It develops and commercializes heart valve products …
  • Avanti Energy Inc (AVN):企業の財務・戦略的SWOT分析
    Summary Avanti Energy Inc (Avanti Energy), formerly known as Overlord Capital Ltd is an oil and gas exploration and production company. The company acquires, explores, and develops gas reserves in Central Italy. It re-develops the existing oil and gas reserves. Avanti Energy owns the Colle Santo gas …
  • Boiron SA:企業の戦略・SWOT・財務分析
    Boiron SA - Strategy, SWOT and Corporate Finance Report Summary Boiron SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • INFINITT Healthcare Co., Ltd (071200):企業の財務・戦略的SWOT分析
    INFINITT Healthcare Co., Ltd (071200) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Walmart de Mexico y Centroamerica:企業の戦略・SWOT・財務情報
    Walmart de Mexico y Centroamerica - Strategy, SWOT and Corporate Finance Report Summary Walmart de Mexico y Centroamerica - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Exxon Mobil Corp (XOM):企業の財務・戦略的SWOT分析
    Exxon Mobil Corp (XOM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • NIBC Bank NV:電力:M&Aディール及び事業提携情報
    Summary NIBC Bank NV (NIBC), a subsidiary of NIBC Holding NV, is an enterprising bank that provides a range of corporate and consumer banking services. The company specializes in mergers and acquisitions, debt and equity mezzanine, capitalization advisory, leveraged finance and structured finance, a …
  • Eriks NV:企業の戦略・SWOT・財務情報
    Eriks NV - Strategy, SWOT and Corporate Finance Report Summary Eriks NV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • AnaBios Corp:製薬・医療:M&Aディール及び事業提携情報
    Summary AnaBios Corp (AnaBios) is a pre-clinical stage contract research organization that offers drug efficacy studies on human samples. The organization’s products portfolio includes human dorsal root ganglia neuron cultures, human cardiac mesenchymal stem cells, human heart tissue samples, human …
  • King Country Energy Limited:企業の戦略的SWOT分析
    King Country Energy Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • The Princeton Review:企業の戦略的SWOT分析
    The Princeton Review - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Vysarn Ltd (MHM):企業の戦略的SWOT分析
    Vysarn Ltd (MHM) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • KPC Pharmaceuticals Inc (600422):製薬・医療:M&Aディール及び事業提携情報
    Summary KPC Pharmaceuticals Inc (KPC), formerly Kunming Pharmaceutical Corp, a subsidiary of Holley Group Co Ltd, is a manufacturer of botanical drugs and other pharmaceutical products. The company offers panax notoginseng, gastrodine, artemether and special botanical drugs. It also offers drugs suc …
  • Minoryx Therapeutics sl-製薬・医療分野:企業M&A・提携分析
    Summary Minoryx Therapeutics sl (Minoryx) is a clinical stage biotechnology company that develops treatments for life threatening rare diseases. The company provides discovery, preclinical research, development and clinical trial programs. It develops ALD-MIN, morquio B and PCT drugs used for lysoso …
  • Robinson Helicopter Company, Inc.:企業の戦略・SWOT・財務情報
    Robinson Helicopter Company, Inc. - Strategy, SWOT and Corporate Finance Report Summary Robinson Helicopter Company, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • International Business Machines Corporation:企業の戦略・SWOT・財務情報
    International Business Machines Corporation - Strategy, SWOT and Corporate Finance Report Summary International Business Machines Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation …
  • East-Central Iowa Rural Electric Cooperative:発電所・企業SWOT分析
    East-Central Iowa Rural Electric Cooperative - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, inf …
  • Vingroup Joint Stock Co:企業の戦略・SWOT・財務情報
    Vingroup Joint Stock Co - Strategy, SWOT and Corporate Finance Report Summary Vingroup Joint Stock Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Curtiss-Wright Corp (CW):電力:M&Aディール及び事業提携情報
    Summary Curtiss-Wright Corp (Curtiss-Wright) is a manufacturing and service company. It designs, manufactures, and overhauls precision components and provides highly engineered critical function products. The company also provides support services for critical applications. Curtiss-Wright serves cus …
  • BioTex Inc:企業の製品パイプライン分析
    Summary BioTex Inc (BioTex) operates as a medical device company that designs, develops, manufactures and distributes electro-mechanical, optical and software based devices. The company offers sterile and non-sterile disposable products for surgical, non-surgical and interventional procedures in dia …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆